Invention Application
- Patent Title: NOVEL EXOSOME-BASED ANTICANCER AGENT
-
Application No.: US16475052Application Date: 2017-12-29
-
Publication No.: US20200148746A1Publication Date: 2020-05-14
- Inventor: Eun-ee KOH , Eun Jung LEE , Yoo Soo YANG , In-San KIM
- Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Seongbuk-gu, Seoul
- Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: KR Seongbuk-gu, Seoul
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@32fe5226
- International Application: PCT/KR2017/015784 WO 20171229
- Main IPC: C07K14/71
- IPC: C07K14/71 ; C12N9/12 ; A61P35/00
Abstract:
The present invention provides a recombinant exosome and uses thereof. More particularly, the present invention privides a recombinant exosome wherein a phagocytosis promoting protein is presented on the surface thereof.
Public/Granted literature
- US11319360B2 Exosome-based anticancer agent Public/Granted day:2022-05-03
Information query
